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The effects of intracoronary injection of nitroglycerin ,
adenosine, nifedipine and prostacyclin on restoring coro-
nary perfusion during flow-reducing partial coronary
obstruction in anesthetized dogs were studied . Coronary
obstruction was obtained by inflation of an intraluminal
balloon to decrease coronary blood flow and rate of rise
in left ventricular pressure (dP/dt) by approximately 30
to 40 and 10%, respectively. Nitroglycerin (0.01 to 10
ltg/kg per min) increased coronary blood flow and distal
coronary pressure and decreased stenosis resistance as-
sociated with improved left ventricular dP/dt depending
on its dose. In contrast, adenosine (0.3 to 1.0 ltg/kg per
min) decreased coronary blood flowand distal coronary
pressure and intensified stenosis resistance associated
with depression of left ventricular dP/dt. Nifedipine and
prostacyclin caused divergent effects on the coronary
Direct intracoronary injection of nitroglycerin, nifedipine
and other vasodilatory agents is becoming increasingly im-
portant in clinical use 0-5). It is used to restore blood flow
through the affected coronary arterie s and relieve myo-
cardial ischemia during diagnostic and therapeutic coronary
angiography. In addition , it is routinel y performed to pre-
vent reocclu sion of dilated coronary obstructive lesions dur-
ing percutaneous coronary angioplasty and thrombol ysis.
Therefore, this study was designed to simulate the clin ical
situation and evaluate the coronary perfusion-restoring ef-
fects of vasodilators admin istered directly into coronary ar-
teries.
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circulation related to each dose. Nifedipine (0.01 and 0.1
ltg/kg per min) and prostacyclin (0.01 Itglkg per min)
increased coronary blood flow and distal coronary pres-
sure and reduced stenosisresistance. Nifedipine (1.0 Itglkg
per min) and prostacyclin (0.3 Itglkg per min) did not
increase coronary blood flow, but reduced distal coro-
nary pressure and intensified stenosis resistance.
Thus, the vasodilators produced different effects on
restoration of coronary perfusion during pliable severe
coronary stenosis. Nitroglycerin and lower doses of ni-
fedipine and prostacyclin improved coronary perfusion
due to selectiveor preferential dilation oflarge coronary
arteries. Adenosine and higher doses of nifedipine and
prostacyclin had deleterious effects on the coronary cir-
culation due to potent arteriolar vasodilation.
(J Am Coil Cardio/ 1987;9:119-26)
An experimental model for inducing coronary inflow re-
striction and acute myocardial ischemia and testing effects
of vasoactive agents was developed . In this model, coronary
obstruction was produced by inflation of a microbalJoon
within the proximal coronary artery (6-8) , resembling hu-
man coronary lesions that contain some intact smooth mus-
cles and atherosclerotic plaque (9- 1I). With use of this
model of coronary stenosis, in which direct measurements
of coronary blood flow and pressure gradient across the
stenosis could allow calculation of coronary resistance, we
evaluated the quantitative dose-response relations of nitro-
glycerin, adenosine , nifedipine and prostacyclin to coronary
hemodynamics and cardiac performance.
Methods
Experimental preparation. Sixty-four mongrel dogs of
either sex, weighing 10 to 15 kg, were pretreated with
subcutaneous morphine ( I rug/kg), anesthetized with intra-
venous alpha-chloralose (100 mg/kg) and ventilated by a
mechanical respirator with positive pressure, using room air
0735-1097/87/$3.50
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Table 1. Systemic Hemodynamic Effects of Nitroglycerin , Adenosine, Nifedipine and Prostacyclin During Coronary Obstruction
Mean Aortic LV Pressure
Heart Rate Pressure Systolic End-Diastolic LV dP/dt
(beats/min) (mmHg) (mm Hg) (mm Hg) (mm Hg/s)
A. Nitroglycerin
0.001 ltg/kg per min
Preobstruction 130 ± 5.0 102 ± 4.1 128 ± 4.5 6.5 ± 0.7 2,630 ± 186
Preinjection 130 ± 5.2 99 ± 4.0 124 ± 4.2 6.7 ± 0.7 2,503 ± 177*
During injection 131 ± 5.2 98 ± 4.2 123 ± 4.5 6.9 ± 0.7 2,513 ± 172
0.01 ltg/kg per min
Preobstruction 133 ± 5.2 102 ± 4.0 128 ± 4.1 6.4 ± 0.7 2,652 ± 202
Preinjection 135 ± 5.1 100 ± 4.4 125 ± 4.0 6.8 ± 0.8 2,468 ± 196*
During injection 135 ± 4.9 100 ± 4.3 126 ± 4.3 6.9 ± 0.7 2,518 ± 199
0.1 ltg/kg per min
Preobstruction 132 ± 4.7 101 ± 4.3 126 ± 4.8 6.6 ± 0.7 2,650 ± 175
Preinjection 132 ± 4.9 99 ± 4.2 124 ± 4.7 7.0 ± 0.7 2,475 ± 186*
During injection 135 ± 5.2 101 ± 4.5 126 ± 4.8 6.8 ± 0.8 2,603 ± 177*
1.0 ltg/kg per min
Preobstruction 130 ± 5.5 104 ± 4.1 129 ± 4.8 6.2 ± 0.7 2,575 ± 167
Preinjection 132 ± 5.2 100 ± 4.3 125 ± 5.1 6.4 ± 0.8 2,410 ± 164*
During injection 133 ± 5.4 102 ± 4.5 127 ± 4.9 6.0 ± 0.7 2,540 ± 178*
10 Itglkg per min
Preobstruction 129 ± 4.8 104 ± 4.1 128 ± 4.7 6.1 ± 0.8 2,597 ± 173
Preinjection 129 ± 5.1 100 ± 4.3 126 ± 5.2 6.3 ± 0.8 2,426 ± 169*
During injection 133 ± 5.4 98 ± 4.6 125 ± 5.7 6.0 ± 0.7 2,588 ± 163*
B. Adenosine
0.03 ltg/kg per min
Preobstruction 133 ± 5.4 103 ± 5.6 126 ± 5.9 6.4 ± 0.8 2,411 ± 178
Preinjection 135 ± 5.8 102 ± 5.7 124 ± 6.1 6.6 ± 0.8 2,206 ± 174*
During injection 135 ± 5.8 102 ± 5.7 124 ± 6.1 6.6 ± 0.8 2,202 ± 168
0.1 ltg/kg per min
Preobstruction 132 ± 6.0 103 ± 5.7 127 ± 6.3 6.7 ± 0.7 2,400 ± 187
Preinjection 132 ± 5.7 101 ± 5.0 125 ± 6.1 6.8 ± 0.7 2,227 ± 182*
During injection 133 ± 6.0 101 ± 5.1 123 ± 6.5 6.8 ± 0.8 2,198 ± 171
0.3 ltg/kg per min
Preobstruction 132 ± 5.8 103 ± 5.6 127 ± 6.3 6.7 ± 0.8 2,385 ± 182
Preinjection 132 ± 5.6 102 ± 5.4 125 ± 6.1 6.9 ± 0.8 2,201 ± 172*
During injection 135 ± 6.1 100 ± 5.7 122 ± 6.5 6.8 ± 0.9 2,045 ± 196*
1.0 ltg/kg per min
Preobstruction 135 ± 5.6 102 ± 5.4 125 ± 5.8 6.4 ± 0.7 2,418 ± 178
Preinjection 133 ± 5.9 102 ± 5.3 124 ± 5.6 6.5 ± 0.7 2,236 ± 170*
During injection 132 ± 6.3 99 ± 5.1 121 ± 5.5 6.8 ± 0.8 1,964 ± 194*
(continued)
supplemented with oxygen. Blood gases and acid/base bal-
ance were maintained within normal limits. A catheter was
passed through the right femoral artery and advanced into
the aortic arch for aortic pressure monitoring. A left tho-
racotomy was performed and the heart was suspended in a
pericardial cradle. A stiff catheter, 10 cm long, was inserted
into the left ventricle through the apex to record left ven-
tricular pressure and rate of rise of pressure (dP/dt). The
left common carotid artery was exposed and a 0.5 to I em
segment of the left circumflex coronary artery was dissected
free. After administration of heparin, 5,000 units, the cir-
cumflex artery was ligated, promptly cannulated with a thin
metal cannula (inner diameter, 2.4 mm) and continuously
perfused from the left carotid artery through the perfusion
tubing with a minimum inner diameter of 2.4 mm. Heparin,
2,000 units, was supplemented every 30 minutes.
Coronary perfusion pressure at the tip of the cannula was
measured , and it was confirmed that mean coronary per-
fusion pressure and mean aortic pressure were identical in
each experiment. In addition, the adequacy of this perfusion
system was demonstrated by preserved autoregulatory re-
serve greater than 300% peak reactive hyperemic response
after a 15 second total coronary occlusion in each dog .
Circumflex coronary blood flow was measured with an ex-
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Table 1. (continued)
LV Pressure
Mean Aortic
Heart Rate Pressure Systolic End-Diastolic LV dP/dt
(beats/min) (mm Hg) (mm Hg) (mm Hg) (mm Hg/s)
C. Nifedipine
0.001 ILg/kg per min
Preobstruction 132 ± 6.8 103 ± 4.8 127 ± 5.6 6.5 ± 0.8 2,525 ± 189
Preinjection 131 ± 6.6 101 ± 4.5 \24 ± 5.3 6.9 ± 1.0 2,313 ± 177*
During injection 132 ± 6.7 100 ± 4.7 122 ± 5.1 7.0 ± 0.9 2,288 ± 171
0.01 ILg/kg per min
Preobstruction 132 ± 6.8 104 ± 4.4 129 ± 5.0 6.1 ± 0.7 2,563 ± 185
Preinjection 134 ± 7.3 101 ± 4.4 125 ± 4.8 6.4 ± 0.8 I 2,388 ± 167*
During injection 133 ± 7.3 100 ± 4.2 124 ± 5.1 6.4 ± 0.9 2,438 ± 169
0.\ ILg/kg per min
Preobstruction 133 ± 7.2 104 ± 4.5 127 ± 5.6 6.0 ± 0.9 2,600 ± 179
Preinjection 134 ± 7.4 101 ± 4.4 124 ± 5.4 6.2 ± 1.0 2,394 ± 159*
During injection 132 ± 6.9 102 ± 4.5 125 ± 5.4 5.9 ± 1.0 2,519 ± 171*
I. 0 ILg/kg per min
Preobstruction 129 ± 6.9 101 ± 4.7 124 ± 5.6 6.8 ± 0.8 2,463 ± 181
Preinjection 130 ± 6.4 98 ± 5.0 120 ± 5.9 7.0 ± 1.0 2,300 ± 160*
During injection 127 ± 6.3 96 ± 4.7 \14 ± 5.7t 7.4 ± 0.9 2,025 ± 163t
D. Prostacyclin
0.001 ILg/kg per min
Preobstruction 134 ± 6.6 101 ± 5.8 123 ± 6.3 6.8 ± 0.6 2,462 ± 176
Preinjection \36 ± 6.7 100 ± 5.5 122 ± 6.1 7.0 ± 0.6 2,290 ± 186*
During injection 136 ± 6.7 100 ± 5.6 120 ± 6.4 7.\ ± 0.6 2,284 ± 188
0.01 ILg/kg per min
Preobstruction 138 ± 6.7 103 ± 6.0 126 ± 6.5 7.3 ± 0.6 2,520 ± 173
Preinjection 136 ± 6.9 103 ± 5.8 124 ± 6.2 7.6 ± 0.7 2,316 ± 176*
During injection 136 ± 6.7 102 ± 5.9 124 ± 6.4 7.5 ± 0.6 2,401 ± 169
0.1 ILg/kg per min
Preobstruction 136 ± 6.4 99 ± 5.9 122 ± 6.0 7.0 ± 0.6 2,483 ± 178
Preinjection \36 ± 6.5 101 ± 5.9 122 ± 6.2 7.1 ± 0.6 2,311 ± 188*
During injection 134 ± 6.7 99 ± 6.2 121 ± 6.3 7.1 ± 0.6 2,264 ± 186
0.3 ILg/kg per min
Preobstruction 134 ± 6.6 lOl ± 6.1 125 ± 6.2 7.4 ± 0.6 2,381 ± 174
Preinjection 135 ± 6.8 100 ± 6.2 123 ± 6.4 7.4 ± 0.6 2,196 ± 180*
During injection 132 ± 6.9 97 ± 6.8 119 ± 7.0 7.8 ± 0.7 2,084 ± 210
*p < 0.05 or tp < 0.01 compared with value above; dP/dt = rate of rise of ventricular pressure; LV = left ventricular.
tracorporeal electromagnetic flow probe (Nihon koden MF-
26, inner diameter 3 mm). A polyethylene catheter was
placed in a small branch of the circumflex coronary artery
distal to the occlusion site to record distal coronary pressure.
Pressures were measured with Statham transducers (P23Db).
Measurements of heart rate and all systemic and coronary
hemodynamic variables were continuously recorded. The
preparation was allowed to stabilize for at least 30 minutes
after coronary cannulation.
Partial coronary obstruction was produced by an infla-
tion of the specially made microballoon occluder, consisting
of a minute rubber balloon attached to the tip of polyethylene
tubing (outer diameter 0.6 mm). The construction of the
microballoon occluder and the characteristics of the exper-
imental model were reported previously (6-8). This occlu-
der was inserted through the side arm of the perfusion tubing
and advanced into the intact proximal portion of the cir-
cumflex coronary artery. There was no major branch be-
tween the cannula and the occluder. It was ascertained that
placement of the microballoon occluder in the coronary
artery affected neither coronary blood flow at rest and its
phasic pattern nor the peak reactive hyperemic response
before operation of the balloon occluder. The size of the
balloon was finely adjusted by expansion with saline so-
lution sufficient to reduce coronary blood flow at rest by
approximately 30 to 40%, and the expansion volume was
kept constant. Stenosis resistance was calculated by dividing
mean pressure gradient across the stenosis by mean coronary
blood flow. Mean pressure gradient was calculated as mean
aortic pressure minus mean distal coronary pressure.
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Figure 1. Effects of nitroglycerin on coronary blood flow (CSF),
mean distal coronary pressure (DCP) and stenosis resistance (SR)
with and without coronary obstruction . The data are expressed as
the values (mean ± SEM) at preinjection (P) and at the end of
injection (I) . *Compared with preinjection, p < 0.05; **compared
with preinjection, p < 0.01.
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were not significantly different among distinct doses of each
vasodilator and groups .
Effects of nitroglycerin (Table lA, Fig. 1). In the ab-
sence of coronary obstruction, intracoronary nitroglycerin
(0.001 to 1.0 JLg/kg per min) did not affect coronary blood
flow. Nitroglycerin (10 JLg/kg per min) significantly in-
creased coronary blood flow by 57 ± 4.6%. No dose of
nitroglycerin had an effect on heart rate , mean aortic pres-
sure , left ventricular systolic and end-diastolic pressures and
left ventricular dP/dt.
Application of partial coronary obstruction decreased
coronary blood flow, mean distal coronary pressure and left
ventricular dP/dt by 38%, 46 mm Hg and II %, respectively
(mean values for all experiments). During partial coronary
obstruction, intracoronary injection of nitroglycerin (0.0 I
JLg/kg per min) increased coronary blood flow by 14 ±
5.4% and reduced stenosis resistance by 24 ± 8.4%. Ni-
troglycerin (0.1, 1.0 and 10 JLg/kg per min) augmented
coronary blood flow by 39 ± 6.6, 53 ± 9.1 and 109 ±
18.3%, increased mean distal coronary pressure by 19 ±
2.7,24 ± 3.0 and 25 ± 3.9 mm Hg and reduced stenosis
Experimental protocol. The effects of intracoronary
injection of nitroglycerin, adenosine, nifedipine and pros-
tacyclin were examined in the presence and absence of par-
tial coronary obstruction . The dogs were divided into four
separate treatment groups in which each agent was admin-
istered. Each group was divided into two subgroups, eight
dogs without coronary obstruction and eight dogs with par-
tial coronary obstruction. In the ischemic series, partial
coronary obstruction was produced after control recording
at rest. Under both conditions, a 10 minute stabilization
period was allowed before drug administration, and then an
intracoronary injection \WlS performed through the coronary
perfusion line at a rate of 0.2 ml/min. It was confirmed that
this perfusion rate of physiologic saline solution and a ve-
hicle of the vasodilators did not affect coronary hemody-
namic variables, and that the transit time between injection
site and cannula tip was less than a few seconds in the
presence and absence of coronary obstruction in the prelim-
inary examinations.
The effect s of nitroglycerin (0.001, 0.01, 0.1 , 1.0 and
10 JLg/kg per min) for 2 minutes, adenosine (0.03, 0.1,0 .3
and 1.0 JLg/kg per min) for 2 minutes , nifedipine (0.001,
0.01, 0.1 and 1.0 JLg/kg per min) for 3 minutes and pros-
tacyclin (0.001, 0.01, 0.1 and 0.3 JLg/kg per min) for 3
minutes were evaluated in each group. The infusion periods
were determined by the periods sufficient to obtain the con-
stant coronary effects of each agent in the presence and
absence of coronary obstruction . The sequence of the doses
of vasodilators to be examined was selected randomly, ex-
cept for the highest dose of nifedipine. The effects of ni-
fedipine (1.0 JLg/kg per min) were examined at the last trial ,
because its action was long-lasting, to obtain complete re-
covery of hemodynamic variables. There was a 30 minute
interval between respective drug injection for recovery. Re-
sults were uninfluenced by the sequence of doses. At the
conclusion of each experiment, dye injection at the same
infusion rate and period was performed , and uniform stain-
ing of the distal circumflex coronary artery bed was re-
vealed .
Statistical analysis. The mean and standard error of the
mean (SEM) were calculated for all variables. Data for a
single response in the same dog were analyzed by the t test
for paired comparison. Differences among the different doses
of each agent and groups were analyzed by analysis of
variance and Tukey's test.
Results
There were no significant hemodynamic differences in
preinjection values in dogs without coronary obstruction or
in control values at rest in the dogs subsequently undergoing
partial coronary obstruction among the four treatment groups.
Preinjection values in dogs with partial coronary obstruction
o
H
-.\~\~\..
p I P I P I P I P I
0.001 0.01 0.1 1.0 10
Nitroglycerin lpg/kg/mini
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resistance by 59 ± 5.3, 70 ± 3.9 and 78 ± 6.9%, re-
spectively, associated with an improvement of left ventric-
ular dP/dt.
Effects of adenosine (Table 18, Fig. 2). In the absence
of coronary obstruction, intracoronary adenosine (0.1 to 1.0
jLg/kg per min) increased coronary blood flow in a dose-
dependent manner up to 108 ± 9.5% at the highest dose
without any significant changes in systemic hemodynamic
variables.
Partial coronary obstruction elicited reductions in coro-
nary blood flow: mean distal coronary pressure and left
ventricular dP/dt by 31%,40 mm Hg and 10%, respectively.
In the presence of partial coronary obstruction, adenosine
(0.03 and 0.1 jLg/kg per min) did not cause significant
changes in coronary hemodynamic variables. Adenosine (0.3
and 1.0 jLg/kg per min) decreased coronary blood flow by
17 ± 7.0 and 54 ± 9. I%, reduced mean distal coronary
pressure by 10 ± 1.3 and 25 ± 3. I mm Hg and produced
a 1.6-fold and 3.6-fold intensification in stenosis resistance,
respectively, associated with a depression in left ventricular
dP/dt.
Effects of nifedipine (Table Ie, Fig. 3). In dogs with-
out coronary obstruction, intracoronary nifedipine (0.001
and 0.01 jLg/kg per min) did not increase coronary blood
flow. Nifedipine (0.1 and 1.0 jLg/kg per min) increased
coronary blood flow by 32 ± 3.4 and 102 ± 9.4%, re-
spectively. Systemic hemodynamic variables did not change,
with the exception of a significant depression in left ven-
tricular systolic pressure and dP/dt during injection of the
highest dose of nifedipine (1.0 jLg/kg per min) by 7 ± 0.9
(p < 0.05) and 244 ± 37 mm Hg/s (p < 0.0 I), respectively.
Partial coronary obstruction decreased coronary blood
flow, mean distal coronary pressure and left ventricular dP/dt
by 32 ± 2.8%, 39 ± 2.4 mm Hg and 12%, respectively.
Nifedipine (0.01 and 0.1 jLg/kgper min) increased coronary
blood flow by 15 ± 5.9 and 50 ± 11.6% and mean distal
coronary pressure by 6 ± 2.9 and 14 ± 3.9 mm Hg, and
decreased stenosis resistance by 26 ± 8.8 and 47 ± 10.9%,
respectively. Left ventricular dP/dt was improved signifi-
cantly by injection of nifedipine (0.1 jLg/kg per min). Ni-
fedipine (1.0 jLg/kg per min) failed to increase coronary
blood flow associated with a significant reduction in mean
distal coronary pressure and left ventricular dP/dt and a two-
fold increase in stenosis resistance.
Effects of prostacyclin (Table ID, Fig. 4). In the ab-
sence of coronary obstruction, prostacyclin caused dose-
Figure 2. Effects of adenosine on coronary blood flow (CBF),
mean distal coronary pressure (DCP) and stenosis resistance (SR)
with and without coronary obstruction. Other abbreviations and
symbols as in Figure I.
Figure 3. Effects of nifedipine on coronary blood flow (CBF),
mean distal coronary pressure (DCP) and stenosis resistance (SR)
with and without coronary obstruction. Other abbreviations and
symbols as in Figure I.
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Discussion
The results of this study demonstrate that, in the presence
of pliable severe coronary stenosis, nitroglycerin increased
coronary blood flow and reduced stenosis resistance, whereas
adenosine decreased coronary blood flow and intensified
stenosis resistance in a dose-dependent manner. Nifedipine
and prostacyclin produced divergent responses; lower doses
of these agents increased coronary blood flow and decreased
stenosis resistance, but higher doses failed to augment coro-
nary.blood flow in association with intensified stenosis re-
sistance.
Partial coronary obstruction model. Direct intracor-
onary injection of vasodilatory drugs such as nitroglycerin,
nifedipine and prostacyclin is now an important diagnostic
and therapeutic aid (1-5). This investigation was designed
to simulate the clinical situation and evaluate restoring ef-
fects of the vasodilators on coronary perfusion. The exper-
imental model used in this study for inducing coronary flow
reduction and acute myocardial ischemia is suitable for this
purpose. In this model, coronary inflow of the left circum-
flex coronary artery was restricted by inflation of the micro-
balloon in the artery (6-8). This coronary obstruction pre-
served active vasomotion in a stenosed segment and was
capable of changing its severity as a result of alterations of
large coronary arterial tone, resembling human atheroscle-
rotic coronary lesions that contain some intact smooth mus-
cles and maintain stenosis vasomobility (9-11). The inad-
equate coronary artery inflow induced by severe partial
coronary obstruction caused significant depression in left
ventricular dP/dt, a manifestation of acute myocardial isch-
emia. Although regional blood flow was not measured in
this study, restricted coronary inflow induces the transmural
redistribution of myocardial blood flow, resulting in sub-
endocardial underperfusion and ischemia (12). The auto-
regulatory reserve in the subendocardiurrt is almost com-
pletely exhausted, whereas some reserve is still present in
the subepicardium. Under these conditions, the effects of
the agents on coronary vasculature and cardiac performance
were evaluated.
Figure 5 provides an aid in understanding the differential
effects of the four vasodilatory agents on coronary perfusion
and distinct segments of the coronary vasculature (that is,
large epicardial and small resistance vessels).
Effects of nitroglycerin. Nitroglycerin at any dose ex-
cept the highest dose of 10 p,g/kg per min did not increase
coronary blood flow in the absence of coronary obstruction.
Significant dilatory effects on small coronary vessels were
induced only by the highest dose of nitroglycerin. During
partial coronary obstruction, nitroglycerin caused dose-
dependent increases in coronary blood flow and mean distal
coronary pressure and a decrease in stenosis resistance. These
findings indicate that nitroglycerin in doses of 0.0 I and 1.0
P 1
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dependent increases in coronary blood flow, appearing at
doses of more than 0.01 p,g/kg per min and reaching 87 ±
11.2% at the highest dose of 0.3 p,g/kg per min. There were
no significant changes in systemic hemodynamic variables.
Application of coronary obstruction decreased coronary
blood flow and mean distal coronary pressure by 31% and
40 mm Hg, respectively; associated with a 9% reduction in
left ventricular dP/dt. During partial coronary obstruction,
prostacyclin caused divergent dose-related responses of the
coronary circulation. At a dose of 0.01 p,g/kg per min,
prostacyclin increased coronary blood flow and mean distal
coronary pressure by 18 ± 4.5% and 9 ± 1.2 mm Hg,
respectively, and reduced stenosis resistance by 25 ± 3.6%.
At a dose of 0.1 p,g/kg per min, it did not cause significant
changes in coronary and systemic hemodynamics. In con-
trast to 0.01 p,g/kg per min of this agent, a dose of 0.3
p,g/kg per min reduced coronary blood flow and mean distal
coronary pressure by 23 ± 11.9% and 22 ± 3.5 mm Hg,
respectively, and intensified stenosis resistance by 135 ±
26%, associated with a significant depression in left ven-
tricular dP/dt.
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ILg/kg per min diminished coronary obstruction and aug-
mented coronary blood flow as a result of selective large
coronary vasodilation, Although the contribution of large
normal coronary vessels to total coronary vascular resistance
is small (13), during flow-reducing severe coronary stenosis,
the large coronary arteries may be crucial in regulating coro-
nary perfusion by changing stenosis severity (14), Even the
highest dose of nitroglycerin caused more potent and pre-
dominant dilation of large vessels as compared with that of
small resistance vessels, These results are in accord with
previous reports (13,15,16), Left ventricular dP/dt was im-
proved during nitroglycerin infusion at doses of 0, I to 10
ILg/kgper min, suggesting an alleviation of myocardial isch-
emia induced by coronary flow restriction.
Effects of adenosine. Adenosine remarkably increased
coronary blood flow in the absence of coronary obstruction,
In contrast, this agent decreased coronary blood flow and
intensified stenosis resistance during partial coronary ob-
struction, This deleterious response of the coronary vas-
culature to adenosine can be explained by the mechanism
for passive narrowing of the stenosed segment (17), Al-
though in vitro experiments (16) have demonstrated the
dilatory effects of adenosine on large and small coronary
arteries, in our in vivo study, potent dilation of small re-
sistance vessels in response to adenosine caused a decrease
in intraluminal distending pressure and nullified the stenosis-
dilatory effects of this agent due to an increase in large
vessel diameter, resulting in a paradoxic intensification of
stenosis severity and a deterioration of coronary perfusion.
Recently, Hintze and Vatner (18) reported that dipyrida-
mole, whose mechanism of action involves the metabolism
of adenosine, could markedly dilate the large epicardial
coronary arteries in intact conscious dogs. In contrast to
studies using a normal heart without coronary stenosis, flow-
dependent vasodilation of large coronary arteries was almost
excluded by the presence of severe coronary obstruction
Figure 5. Percentchange in coronary blood flow in response to
various doses of nitroglycerin, nifedipine, prostacyclin and aden-
osine with and withoutcoronaryobstruction, DUring partial coro-
nary obstruction, the responses to nitroglycerin and adenosineare
opposite, and the responses to nifedipine and prostacyclin are
divergent. *Compared with preinjection, p < 0,05; **compared
with preinjection p < 0,01,
(19). In addition, an unfavorable effect of adenosine (that
is, the risk of coronary steal and diversion of myocardial
blood flow from subendocardium to subepicardium) must
be considered (20), A reduction in left ventricular dP/dt
during administration of adenosine in doses of 0.3 and 1,0
ILg/kg per min reflected a deterioration of myocardial isch-
emia,
Effects of nifedipine and prostacyclin. In the absence
of coronary obstruction, nifedipine and prostacyclin produced
dose-dependent increases in coronary blood flow, During
partial coronary obstruction, these agents caused divergent
responses of coronary hemodynamic variables related to
each dose, Low doses of nifedipine (0.01 and 0, I ILg/kg
per min) had selective or preferential dilatory effects on
large coronary arteries, as demonstrated by restored coro-
nary perfusion and reduced stenosis severity, These prom-
inent dilatory responses of large coronary arteries to nifed-
ipine were previously demonstrated as assessed by
measurement of coronary diameter in intact dogs (21), Pros-
tacyclin in a dose of 0,01 ILg/kg per inin had preferential
but feeble dilatory effects on large coronary arteries and no
dose of this agent had a selective dilatory effect on large
vessels, In contrast to lower doses of these agents, higher
doses of nifedipine (1.0 ILg/kg per min) and prostacyclin
(0,3 ILg/kg per min) had a deleterious effect on coronary
vasculature due to potent dilation of small resistance vessels.
The mechanism of this deleterious response to higher doses
of these drugs can be passive narrowing as occurs with
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adenosine. Left ventricular systolic pressure and dP/dt were
significantly depressed during the highest dose of nifedipine
in the presence and absence of coronary obstruction, con-
firming several studies (4) indicating that intracoronary ni-
fedipine has negative inotropic effects. It was reported (22)
that lowered coronary perfusion pressure increased stenosis
resistance. Therefore, the negative inotropic action as well
as the small decrease in left ventricular systolic pressure
contribute to the deleterious effects of the highest dose of
nifedipine in this setting.
Clinical implications. The vasodilatory agents studied
caused comparative responses of coronary vasculature in
the presence of flow-reducing severe coronary obstruction
which preserved its vasomobility. Our results showed that
coronary flow-restoring effects of the vasodilators depend
on their potency and preference for dilatory effects on large
epicardial coronary arteries. In contrast, dilatory effects on
small resistance vessels exerted an unfavorable effect on the
obstructive coronary segment. Therefore, the selection of
vasodilatory agent and its dose are clinically important dur-
ing direct injection of any vasodilator into coronary arteries
with severe obstructive lesions. It should be noted that the
effects of vasodilators may be greater in this experimental
model than in an atherosclerotic artery, because the entire
arterial wall in the stenosed area is normal in the micro-
balloon obstruction, as opposed to an atherosclerotic artery
in which only a portion of the arterial wall in the obstructive
area may be normal.
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